Shares of Kodak are up over 1000% this week on the news that the camera company received a $700 million loan to build out capabilities to manufacture active pharmaceutical ingredients. The news is a shot in the arm for a struggling business and a move that brings key operations onto U.S. soil. We talk about that, plus all-you-can-fly passes in China and whether they could make their way to the U.S.
Podden och tillhörande omslagsbild på den här sidan tillhör The Motley Fool. Innehållet i podden är skapat av The Motley Fool och inte av, eller tillsammans med, Poddtoppen.
